Latest Cancer News

Palbociclib/Letrozole Improves Outcomes of Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer (02-27-2015)
The results of the phase II PALOMA-1/TRIO-18 trial were recently reported in The Lancet Oncology and suggest that the addition of Ibrance® (palbociclib) to Femara® (letrozole) delayed the time to cancer... Continue Reading

FDA Grants Breakthrough Therapy Designation for MPDL3280A, an anti-PDL1 Investigational Cancer Immunotherapy for Non-Small Cell Lung Cancer (02-26-2015)
The investigational cancer immunotherapy MPDL3280A (anti-PDL1) has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA). The designation was granted for the treatment... Continue Reading

Farydak® Approval Provides Another Treatment Option for Patients With Multiple Myeloma (02-25-2015)
Novartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat) in combination with Velcade® and dexamethasone for the treatment of patients with multiple... Continue Reading

More Cancer News

Locations

 
 

The Center At Boca Raton
701 NW 13th St.
2nd Floor
Boca Raton, FL 33486
TEL: (561) 955-6400
FAX: (561) 750-7662

 
 
 

The Center At Delray Beach
6282 Linton Blvd.
Delray Beach, Florida 33484
TEL: (561) 495-8307
FAX: (561) 495-6422

 
 
 
Click here for the Lynn Cancer Institute